Correction
After the publication of this work [1] an error in Fig. 1c was brought to our attention: the Western blots for PRDX6 and β-actin were similar to those shown in lanes 5-6 of Fig. 4g. To verify these findings, we have repeated this experiment and the results are shown in a new Fig. 1c below. The repeated experimental results are consistent with the previously reported findings in the original study [1] and the functional role for PRDX6 in malignant progression of human cancer including breast cancer has been widely documented and recognized in numerous other studies [2]. We apologize for the error. However, this correction does not affect the conclusions of the article.
c Western blot analysis of PRDX6 and GAPDH expression in MDA-MB-231HM (lane 2) and parental MDA-MB-231 cell line (lane 1)
References
Shao Z, et al. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 2007;9:R76.
Coppa A, et al. The role of peroxiredoxins in cancer. Mol Clin Oncol. 2017;6(2):139–53.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Chang, XZ., Li, DQ., Hou, YF. et al. Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 20, 63 (2018). https://doi.org/10.1186/s13058-018-0984-0
Published:
DOI: https://doi.org/10.1186/s13058-018-0984-0